GE HealthCare Technologies (NASDAQ:GEHC) Given New $91.00 Price Target at BTIG Research

GE HealthCare Technologies (NASDAQ:GEHC) had its target price increased by BTIG Research from $87.00 to $91.00 in a research report report published on Wednesday, MarketBeat Ratings reports. The brokerage currently has a buy rating on the stock.

Other equities research analysts have also issued research reports about the company. Wells Fargo & Company reduced their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a research report on Wednesday, January 7th. Finally, Citigroup lifted their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $91.33.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $82.58 on Wednesday. The firm has a 50 day moving average of $82.68 and a two-hundred day moving average of $77.47. The stock has a market capitalization of $37.62 billion, a PE ratio of 17.06, a P/E/G ratio of 2.38 and a beta of 1.08. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, research analysts predict that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Hedge Funds Weigh In On GE HealthCare Technologies

Several large investors have recently bought and sold shares of the stock. Allianz SE lifted its holdings in shares of GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. increased its position in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after buying an additional 196 shares during the period. Godsey & Gibb Inc. purchased a new stake in GE HealthCare Technologies in the third quarter valued at approximately $26,000. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at approximately $26,000. Finally, Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies during the fourth quarter worth approximately $27,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Key Stories Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 beat — GE HealthCare reported Q4 EPS of $1.44 and revenue of $5.7B, topping Street estimates and showing 7.1% YoY revenue growth; investors often reward beats even when margins are pressured. Article Title
• Positive Sentiment: FY‑2026 guidance nudges above consensus — management set EPS guidance of $4.95–$5.15, modestly above the Street forecast, signaling confidence in sustained device demand. Article Title
• Positive Sentiment: Analyst upgrade/target raise — BTIG raised its price target to $91 and maintained a buy rating, offering upward analyst momentum that can drive buying interest. Article Title
• Positive Sentiment: Product/regulatory progress — FDA clearance and CE mark for the Allia Moveo (mobile C‑arm) enable commercialization and early global installs, supporting growth in Imaging/PDx. Article Title
• Neutral Sentiment: Investor materials and call — Management hosted the earnings call and posted slides/transcript; useful for investors wanting detail on segment trends, backlog, and capital allocation. Article Title
• Negative Sentiment: Margin pressure — Net margin declined due to tariffs, adverse product mix and investments; profit fell YoY despite higher revenue, which keeps scrutiny on margin recovery going forward. Article Title Article Title

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.